Synthesis and characterization of peptides containing a cyclic val adduct of diepoxybutane, a possible biomarker of human exposure to butadiene

Chemical Research in Toxicology

Volumn 16, Issue 5, 2003, Pages 637-643

  Jayaraj, K ^a   Georgieva, Nadia I ^a   Gold, Avram ^a   Sangaiah, R ^a   Koc, Hasan ^a   Klapper, David G ^a   Ball, Louise M ^a   Reddy, Anantha P ^b   Swenberg, James A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; BIOLOGICAL MARKER; BUTADIENE DIEPOXIDE; BUTYRIC ACID DERIVATIVE; CARCINOGEN; CYTOCHROME P450; HAPTEN; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; POLYCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ARTICLE; CHEMICAL MUTAGENESIS; CHEMICAL REACTION; DIASTEREOISOMER; DOSIMETRY; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCUPATIONAL TOXICOLOGY; OXIDATION; PEPTIDE SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALIA;

EID: 0037568060     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx020099i     Document Type: Article

References (14)

1. Department of Health and Human Services (2000) U. S. Public Health Service, National Toxicology Program, The Ninth Report on Carcinogens, Research Triangle Park, NC.
2. Cochrane, J. E., and Skopek, T. R. (1994) Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutane, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butane diol in cultured human lymphoblasts. Carcinogenesis 15, 713-717.
3. Kemper, R. A., Krause, R. J., and Elfarra, A. A. (2001) Metabolism of butadiene monoxide by freshly isolated hepatocytes from mice and rats: different partitioning between oxidative, hydrolytic, and conjugation pathways. Drug Metab. Dispos. 29, 830-836.
4. Krause, R. J., and Elfarra, A. A. (1997) Oxidation of butadiene monoxide to meso-and (±)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: Evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. Arch. Biochem. Biophys. 337, 176-184.
5. Swenberg, J. A., Koc, H., Upton, P. B., Georguieva, N., Ranasinghe, A., Walker, V. E., and Henderson, R. (2001) Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chem.-Biol. Interact. 135-136, 387-403.
6. Nieusma, J. L., Claffey, J. C., Maniglier-Poulet, C., Imiolczyk, T., Peter, R. M., Ross, D., and Ruth, J. A. (1997) Stereochemical aspects of 1,3-butadiene metabolism and toxicity in rat and mouse liver microsomes and freshly isolated rat hepatocytes. Chem. Res. Toxicol. 10, 450-456.
7. Irons, R. D., Pyatt, D. W., Stillman, W. S., Som, D. B., Claffey, D. J., and Ruth, J. A. (2000) Comparative toxicity of known and putative metabolites of 1,3-butadiene in human CD34+ bone marrow cells. Toxicology 150, 99-106.
8. Rydberg, P., Magnusson, A.-L., Zorcec, V., Granath, F., and Törnqvist, M. (1996) Adducts to N-terminal valines in hemoglobin from butadiene metabolites. Chem.-Biol. Interact. 101, 193-205.
9. Törnqvist, M., Mowrer, J., Jensen S., and Ehrenberg, L. (1986) Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal. Biochem. 154, 255-266.
10. Kautiainen, A., Fred, C., Rydberg P., and Törnqvist, M. (2000) A liquid chromatography tandem mass spectrometric method for in vivo dose monitoring of diepoxybutane, a metabolite of butadiene. Rapid Commun. Mass Spectrom. 14, 1848-1853.
11. Carpino, L. A., and Han, G. Y. (1972) The 9-fluorenylmethoxy-carbonyl amino-protecting group. J. Org. Chem. 37, 3404-3409.
12. Micheli, R. A., Hajos, Z. G., Cohen, N., Parish, D. R., Portland, L. A., Sciamanna, W., Scott M. A., and Wherli, P. A. (1975) Total synthesis of optically active 19-norsteroids. (+)-Estr-4-ene-3,17-dione and (+)-13β-ethylgon-4-ene-3,17-dione. J. Org. Chem. 40, 675-681.
13. Ireland, R. E., O'Neil, T. H., and Tolman, G. L. (1990) Reductive cleavage of vinyl phosphordiamidates: 17,β-tert-butoxy-5α-an drost-2-ene. Organic Syntheses; Collect. Vol. VII, pp 66-69, Wiley & Sons, New York.
14. Callahan, F. M., and Zimmerman, J. E. (1967) Hydroxy amino acid derivatives. U.S. Patent No. 3,340,274 (American Cyanamid Co.); Chem. Abstr. 68, P59875w.